Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin type A injections improved hair growth and scalp health in a woman with radiation-induced hair loss.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

Early surgical intervention and a multidisciplinary approach are crucial for managing complex cardio-obstetric patients.

Obesity greatly affects polycystic ovarian syndrome, and losing weight should be the first treatment for obese patients to improve their chances of ovulation and pregnancy.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Common skin conditions can greatly affect a person's mental health and social life.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.